MA32453B1 - Manoparticules inograniques, leur preparation et leurs utilisations - Google Patents

Manoparticules inograniques, leur preparation et leurs utilisations

Info

Publication number
MA32453B1
MA32453B1 MA33490A MA33490A MA32453B1 MA 32453 B1 MA32453 B1 MA 32453B1 MA 33490 A MA33490 A MA 33490A MA 33490 A MA33490 A MA 33490A MA 32453 B1 MA32453 B1 MA 32453B1
Authority
MA
Morocco
Prior art keywords
particles
relates
health
vivo
field
Prior art date
Application number
MA33490A
Other languages
Arabic (ar)
English (en)
French (fr)
Inventor
Laurent Levy
Agnès Pottier
Annabelle Rouet
Julie Marill
Corinne Devaux
Matthieu Germain
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Publication of MA32453B1 publication Critical patent/MA32453B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Radiation-Therapy Devices (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MA33490A 2008-06-05 2011-01-04 Manoparticules inograniques, leur preparation et leurs utilisations MA32453B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08157686A EP2130553A1 (en) 2008-06-05 2008-06-05 Inorganic nanoparticles of high density to destroy cells in-vivo
US6020208P 2008-06-10 2008-06-10
PCT/EP2009/056880 WO2009147214A2 (en) 2008-06-05 2009-06-04 Inorganic nanoparticles, preparation and uses thereof

Publications (1)

Publication Number Publication Date
MA32453B1 true MA32453B1 (fr) 2011-07-03

Family

ID=39734334

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33490A MA32453B1 (fr) 2008-06-05 2011-01-04 Manoparticules inograniques, leur preparation et leurs utilisations

Country Status (26)

Country Link
US (1) US8845507B2 (pt)
EP (4) EP2130553A1 (pt)
JP (1) JP5734181B2 (pt)
KR (1) KR101639281B1 (pt)
CN (1) CN102056628B (pt)
AU (1) AU2009254550B2 (pt)
BR (1) BRPI0913410B1 (pt)
CA (1) CA2727576C (pt)
CY (2) CY1118217T1 (pt)
DK (2) DK3150227T3 (pt)
EA (1) EA023012B1 (pt)
ES (2) ES2702249T3 (pt)
HR (2) HRP20161465T8 (pt)
HU (2) HUE030669T2 (pt)
IL (1) IL209625A (pt)
LT (2) LT2300054T (pt)
MA (1) MA32453B1 (pt)
MX (1) MX2010013322A (pt)
NZ (1) NZ589888A (pt)
PL (2) PL3150227T3 (pt)
PT (2) PT2300054T (pt)
SG (1) SG10201405288WA (pt)
SI (2) SI2300054T1 (pt)
TR (1) TR201819077T4 (pt)
WO (1) WO2009147214A2 (pt)
ZA (1) ZA201100082B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070164238A1 (en) * 2003-02-24 2007-07-19 Pomper Mark E Mobile radiation treatment vehicle and method
US8657354B2 (en) 2006-05-19 2014-02-25 Breya, Llc. Mobile radiation therapy
US8459714B2 (en) 2006-05-19 2013-06-11 Breya, Llc. Mobile radiation therapy
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US8728440B2 (en) 2012-08-23 2014-05-20 General Electric Company Nanoparticulate compositions for diagnostic imaging
US9585840B1 (en) 2009-07-10 2017-03-07 University Of Central Florida Research Foundation, Inc. Redox active cerium oxide nanoparticles and associated methods
EP2275137A1 (en) 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
CN102870235B (zh) * 2009-11-10 2016-11-23 免疫之光有限责任公司 用于从包括用于上变频的射频、微波能量和磁感应源的各种能量源产生发射光的上下变频系统
WO2011133228A2 (en) * 2010-04-23 2011-10-27 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
EP3190083B1 (en) 2010-10-27 2020-08-26 Pixelligent Technologies, LLC Synthesis, capping and dispersion of nanocrystals
US9359689B2 (en) 2011-10-26 2016-06-07 Pixelligent Technologies, Llc Synthesis, capping and dispersion of nanocrystals
EA029635B1 (ru) 2011-12-16 2018-04-30 Нанобиотикс Применение наночастицы, включающей металлический материал, покрытый материалом оксида гафния, в онкологии и композиция, ее содержащая
AU2013274093A1 (en) * 2012-06-14 2014-12-18 Bioventures, Llc Compositions and methods for non-invasive detection and treatment of hypoxic cells in vivo
US8821838B2 (en) 2012-08-23 2014-09-02 General Electric Company Nanoparticulate compositions for diagnostic imaging
AR094577A1 (es) * 2013-01-25 2015-08-12 Nanobiotix Composiciones para el tratamiento de cáncer, preparación y usos de las mismas
KR101999421B1 (ko) * 2013-02-19 2019-07-11 내셔날 헬스 리서치 인스티튜트 항암 화학치료제를 위한 케이지된 백금 나노클러스터
WO2014191569A1 (en) 2013-05-30 2014-12-04 Nanobiotix Pharmaceutical composition, preparation and uses thereof
EA201690050A1 (ru) * 2013-06-20 2016-05-31 Нанобиотикс Композиции и способы для применения в медицинской диагностике
JP6671292B2 (ja) * 2013-12-16 2020-03-25 ジェネンテック， インコーポレイテッド ペプチド模倣化合物及びその抗体−薬物コンジュゲート
EP2886128A1 (en) 2013-12-20 2015-06-24 Nanobiotix Pharmaceutical composition comprising nanoparticles, preparation and uses thereof
EP3229776B1 (en) * 2014-11-25 2023-06-28 Curadigm Sas Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof
SG11201704143YA (en) 2014-11-25 2017-06-29 Nanobiotix Pharmaceutical composition, preparation and uses thereof
EP3223796B1 (en) 2014-11-25 2021-07-21 Curadigm Sas Pharmaceutical compositions, preparation and uses thereof
ES2774365T3 (es) 2014-11-25 2020-07-20 Curadigm Sas Composición farmacéutica, preparación y usos de la misma
UA123665C2 (uk) 2014-11-25 2021-05-12 Кюрадігм Сас Фармацевтична композиція, її одержання і застосування
US20180008733A1 (en) * 2015-01-08 2018-01-11 Purdue Research Foundation Non-toxic formulations of radio-luminescent nanoparticles for use as cancer radio-sensitizing agents
UA124572C2 (uk) * 2015-05-28 2021-10-13 Нанобіотікс Наночастинки для застосування як терапевтичної вакцини
US11389536B2 (en) 2015-07-17 2022-07-19 BioCurity Pharmaceuticals Inc. Treatment of cancer with a combination of radiation, cerium oxide nanoparticles, and a chemotherapeutic agent
CN109010828B (zh) * 2018-10-12 2020-10-20 中国科学院高能物理研究所 一种二硫化钼/二氧化铪的复合纳米材料、其制备方法及用途
CN109616308B (zh) * 2018-11-07 2020-09-04 湖北第二师范学院 一种球形纳米氧化铱dna提取磁性粉末及其生产方法
CN109771645B (zh) * 2019-03-07 2021-08-24 广西师范大学 一种二氧化钌复合卵清蛋白纳米材料的制备及其应用
KR20230038659A (ko) * 2020-05-26 2023-03-21 나노비오띡스 나노 입자, 전리 방사선 및 그의 혁신적인 치료용 조합
CN116507366A (zh) * 2020-11-05 2023-07-28 纳米生物技术公司 用于治疗癌症的纳米颗粒组合物
US20240000940A1 (en) * 2020-12-01 2024-01-04 Nanobiotix S.A. Porous, high-z and carbon-free particles as radioenhancers
AR131316A1 (es) 2022-12-12 2025-03-05 Nanobiotix S A Novedosas nanopartículas de óxido de metal y composiciones de las mismas para uso como radiopotenciadores o para visualizar tejido biológico
EP4595983A1 (en) 2024-02-05 2025-08-06 BXTA Nanotherapy Limited Nanoparticles functionalised with a stabilising agent and a targeting agent
WO2026074471A1 (en) * 2024-10-02 2026-04-09 Janssen Pharmaceutica Nv Combination therapies with hafnium oxide nanoparticles and pd-l1 antibodies for use in the treatment of non small cell lung cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6287526A (ja) * 1985-10-11 1987-04-22 Akira Fujishima 抗腫瘍剤
US6645464B1 (en) 1998-07-30 2003-11-11 James F. Hainfeld Loading metal particles into cell membrane vesicles and metal particular use for imaging and therapy
EP1696957A2 (en) 2003-12-17 2006-09-06 Philips Intellectual Property & Standards GmbH Radiation therapy and medical imaging using uv emitting nanoparticles
FR2869803B1 (fr) 2004-05-10 2006-07-28 Nanobiotix Sarl Particules activables, preparation et utilisations
US20070092927A1 (en) * 2005-06-13 2007-04-26 University Of Dayton Photocatalytic particles with directed and controlled redox activity
JP2007075696A (ja) * 2005-09-13 2007-03-29 Mitsubishi Materials Corp 多孔質光触媒膜
US20090191128A1 (en) * 2006-07-10 2009-07-30 Koninklijke Philips Electronics N.V. Core-shell nanoparticles for thearapy and imaging purposes
EP1920784A1 (en) * 2006-11-13 2008-05-14 Koninklijke Philips Electronics N.V. Radiation sensitizers in ionizing radiation therapy and imaging

Also Published As

Publication number Publication date
EP3150227A1 (en) 2017-04-05
SI2300054T1 (sl) 2017-02-28
BRPI0913410A2 (pt) 2015-11-24
JP5734181B2 (ja) 2015-06-17
HUE040247T2 (hu) 2019-02-28
JP2011524866A (ja) 2011-09-08
PL2300054T3 (pl) 2017-04-28
SG10201405288WA (en) 2014-10-30
HUE030669T2 (en) 2017-05-29
ZA201100082B (en) 2011-10-26
AU2009254550B2 (en) 2013-10-24
CN102056628B (zh) 2013-07-10
US8845507B2 (en) 2014-09-30
EP2130553A1 (en) 2009-12-09
EP3150227B1 (en) 2018-10-31
KR20110028616A (ko) 2011-03-21
AU2009254550A1 (en) 2009-12-10
PL3150227T3 (pl) 2019-05-31
EP3461502A1 (en) 2019-04-03
ES2702249T3 (es) 2019-02-28
WO2009147214A3 (en) 2010-02-25
MX2010013322A (es) 2011-01-21
PT3150227T (pt) 2018-12-24
CA2727576A1 (en) 2009-12-10
NZ589888A (en) 2012-06-29
WO2009147214A2 (en) 2009-12-10
BRPI0913410B1 (pt) 2021-09-21
CN102056628A (zh) 2011-05-11
CY1118217T1 (el) 2017-06-28
EA201071429A1 (ru) 2011-06-30
DK3150227T3 (en) 2019-01-14
IL209625A (en) 2015-11-30
EP2300054A2 (en) 2011-03-30
LT3150227T (lt) 2018-12-10
PT2300054T (pt) 2016-11-11
HRP20161465T1 (hr) 2017-01-27
LT2300054T (lt) 2016-12-27
DK2300054T3 (en) 2016-12-05
IL209625A0 (en) 2011-02-28
EA023012B1 (ru) 2016-04-29
HRP20161465T8 (hr) 2017-04-21
TR201819077T4 (tr) 2019-01-21
EP2300054B1 (en) 2016-09-07
KR101639281B1 (ko) 2016-07-13
CY1121078T1 (el) 2019-12-11
ES2602048T3 (es) 2017-02-17
HRP20181993T1 (hr) 2019-01-25
CA2727576C (en) 2016-08-16
SI3150227T1 (sl) 2019-02-28
US20110213192A1 (en) 2011-09-01

Similar Documents

Publication Publication Date Title
MA32453B1 (fr) Manoparticules inograniques, leur preparation et leurs utilisations
MA33516B1 (fr) Nanoparticules métalliques, leur préparation et leurs utilisations
MA38318A1 (fr) Compositions de nanoparticules inorganiques combinées à des rayonnements ionisants pour le traitement du cancer
Capuano et al. Nanoparticles and their antibacterial application in endodontics
Hossain et al. Advances of nanoparticles employment in dental implant applications
Eick et al. Effect of photoactivated disinfection with a light-emitting diode on bacterial species and biofilms associated with periodontitis and peri-implantitis
Eick et al. In vitro-activity of Er: YAG laser in comparison with other treatment modalities on biofilm ablation from implant and tooth surfaces
Mozayeni et al. Antimicrobial effects of four intracanal medicaments on enterococcus faecalis: an in vitro study
Chen et al. Novel Twin‐Crystal Nanosheets with MnO2 Modification to Combat Bacterial Biofilm against Periodontal Infections via Multipattern Strategies
Maaoui et al. A 980 nm driven photothermal ablation of virulent and antibiotic resistant Gram-positive and Gram-negative bacteria strains using Prussian blue nanoparticles
CO6670567A2 (es) Métodos de tratamiento contra el cáncer pancreático
AR068185A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
PE20090975A1 (es) Terapia de combinacion de un anticuerpo anti-cd20 de tipo ii con un inhibidor de proteasoma
MX2009005727A (es) Nanoparticulas de entidad anfifilica.
CO6311008A2 (es) Composicion farmaceutica que comprende un agente que activa las celulas t regulatorias cd4+cd25+
WO2008093869A1 (ja) 蛍光材料およびそれを用いたシンチレータ並びに放射線検出器
CO6300964A2 (es) Una composicion farmaceutica que comprende una combinacion de un agente quimioterapeutico y un anticuerpo 3 antiglipicano
AR059723A2 (es) Composicion de altas dosis de ibandronato
PE20060002A1 (es) Combinaciones antineoplasicas de cci-779 y rituximab
Gambarini et al. In vitro evaluation of the cytotoxicity of FotoSan™ light-activated disinfection on human fibroblasts
Shariati The cancer therapy materialization by theranostic nanoparticles based on gold doped iron oxide under electromagnetic field amplification
MX2018015916A (es) Compuestos de porfirina y composiciones útiles para el tratamiento de cáncer.
Popova et al. Cerium oxide nanoparticles provide radioprotective effects upon X-ray irradiation by modulation of gene expression
Hassan et al. Antibacterial and Cytotoxicity characteristics of experimental epoxy-based endodontic sealer loaded with silver gold nanoparticles: in vitro study
Shukla et al. Association and contribution of dentistry in creating and sharing the burden of antibiotic-resistant microbial world